Correlation of Natriuretic Peptides with Invasively Measured Intracardiac Filling Pressures in Patients With Cancer.
作者信息
Fatakdawala Mariya M, Ryoo Ali Hyeon-Ju, Song Juhee, Irizarry-Caro Jorge A, Faiz Saadia A, Kumar Salil, Yusuf Syed Wamique, Durand Jean-Bernard, Iliescu Cezar, Palaskas Nicolas, Deswal Anita, Koutroumpakis Efstratios
机构信息
Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
出版信息
JACC CardioOncol. 2025 Jun;7(4):448-450. doi: 10.1016/j.jaccao.2025.03.006. Epub 2025 May 13.
Abstract
摘要
相似文献
1
Correlation of Natriuretic Peptides with Invasively Measured Intracardiac Filling Pressures in Patients With Cancer.癌症患者中利钠肽与有创测量的心腔内充盈压的相关性
JACC CardioOncol. 2025 Jun;7(4):448-450. doi: 10.1016/j.jaccao.2025.03.006. Epub 2025 May 13.
2
Exercise Training in Patients With Hypertrophic Cardiomyopathy Without Left Ventricular Outflow Tract Obstruction: A Randomized Clinical Trial.无左心室流出道梗阻的肥厚型心肌病患者的运动训练：一项随机临床试验。
Circulation. 2025 Jan 14;151(2):132-144. doi: 10.1161/CIRCULATIONAHA.124.070064. Epub 2024 Nov 8.
3
Meta-Analysis of Physical Training on Natriuretic Peptides and Inflammation in Heart Failure.Meta 分析心力衰竭患者的体力训练对利钠肽和炎症的影响。
Am J Cardiol. 2022 Sep 1;178:60-71. doi: 10.1016/j.amjcard.2022.05.012. Epub 2022 Jul 8.
4
Acute dyspnoea in cancer patients: Prevalence of acute heart failure, resource use and diagnostic accuracy of natriuretic peptides.
Eur J Heart Fail. 2025 Jun 30. doi: 10.1002/ejhf.3752.
5
Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient Setting.利钠肽在门诊环境中评估射血分数保留的慢性心力衰竭中的循证应用
Circulation. 2025 Apr 8;151(14):976-989. doi: 10.1161/CIRCULATIONAHA.124.072156. Epub 2025 Jan 22.
6
Natriuretic peptides for heart failure screening in nursing homes: a systematic review.用于养老院心力衰竭筛查的利钠肽：一项系统评价
Heart Fail Rev. 2021 Sep;26(5):1131-1140. doi: 10.1007/s10741-020-09944-w.
7
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations.欧洲心脏病学会心力衰竭协会关于利钠肽浓度检测的临床应用实践指南
Eur J Heart Fail. 2019 Jun;21(6):715-731. doi: 10.1002/ejhf.1494.
8
The usefulness of brain natriuretic peptide in simple congenital heart disease - a systematic review.脑钠肽在单纯性先天性心脏病中的应用——一项系统评价
Cardiol Young. 2013 Jun;23(3):315-24. doi: 10.1017/S1047951112001205. Epub 2012 Sep 21.
9
A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at risk of heart failure.一项系统评价探索了测量心外膜脂肪厚度与 B 型利钠肽水平相关性的意义，作为心力衰竭患者或有心力衰竭风险患者的预后和诊断标志物。
Heart Fail Rev. 2022 Mar;27(2):665-675. doi: 10.1007/s10741-021-10160-3. Epub 2021 Oct 20.
10
A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure.利钠肽对心力衰竭诊断准确性的系统评价。
Arch Intern Med. 2004 Oct 11;164(18):1978-84. doi: 10.1001/archinte.164.18.1978.
本文引用的文献
1
Established and Emerging Roles of Biomarkers in Heart Failure.生物标志物在心衰中的既定和新兴作用。
Circ Res. 2018 Aug 17;123(5):614-629. doi: 10.1161/CIRCRESAHA.118.312706.
2
Plasma brain natriuretic peptide levels are elevated in patients with cancer.癌症患者的血浆脑钠肽水平升高。
PLoS One. 2017 Jun 1;12(6):e0178607. doi: 10.1371/journal.pone.0178607. eCollection 2017.
3
Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality.癌症患者的心血管生物标志物及其与全因死亡率的关联。
Heart. 2015 Dec;101(23):1874-80. doi: 10.1136/heartjnl-2015-307848. Epub 2015 Sep 28.
4
Human small cell lung cancer cells produce brain natriuretic peptide.
Oncology. 1999;56(2):155-9. doi: 10.1159/000011957.
5
Immunoreactive brain natriuretic peptide in human adrenal glands and adrenal tumors.
Eur J Endocrinol. 1996 Sep;135(3):352-6. doi: 10.1530/eje.0.1350352.
Zotero 插件